Welcome! If you have a coupon code, click here to apply it. Apply
stock
Sangamo Therapeutics Inc
NASDAQ | SGMO
0.58
USD
+0.00 ( +0.00%)
AT CLOSE (AS OF Jun 25, 2025)
$126M
MARKET CAP
-
P/E Ratio
-0.36
EPS
$3.2
52 Week High
$0.3
52 Week Low
LIFE SCIENCES
Sector
SGMO Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
SGMO Technicals
SGMO Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $58M |
| Total Revenue | $58M |
| Cost Of Revenue | $9.4M |
| Costof Goods And Services Sold | $9.4M |
| Operating Income | -$104M |
| Selling General And Administrative | $45M |
| Research And Development | $112M |
| Operating Expenses | $162M |
| Investment Income Net | - |
| Net Interest Income | $5.9M |
| Interest Income | $5.9M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $9.4M |
| Income Before Tax | -$98M |
| Income Tax Expense | -$167K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$98M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$98M |
| Ebitda | -$89M |
| Net Income | -$98M |
Revenue & Profitability
Earnings Performance
SGMO Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $102M |
| Total Current Assets | $52M |
| Cash And Cash Equivalents At Carrying Value | $42M |
| Cash And Short Term Investments | $42M |
| Inventory | - |
| Current Net Receivables | $4.6M |
| Total Non Current Assets | $50M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $0 |
| Other Current Assets | $5.2M |
| Other Non Current Assets | - |
| Total Liabilities | $79M |
| Total Current Liabilities | $46M |
| Current Accounts Payable | $15M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $4.3M |
| Total Non Current Liabilities | $33M |
| Capital Lease Obligations | $31M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $31M |
| Other Current Liabilities | $14M |
| Other Non Current Liabilities | $933K |
| Total Shareholder Equity | $23M |
| Treasury Stock | - |
| Retained Earnings | -$1.5B |
| Common Stock | $2.1M |
| Common Stock Shares Outstanding | $202M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$67M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $9.4M |
| Capital Expenditures | $267K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $28M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $290K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$98M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $58M |
| Total Revenue | $58M |
| Cost Of Revenue | $9.4M |
| Costof Goods And Services Sold | $9.4M |
| Operating Income | -$104M |
| Selling General And Administrative | $45M |
| Research And Development | $112M |
| Operating Expenses | $162M |
| Investment Income Net | - |
| Net Interest Income | $5.9M |
| Interest Income | $5.9M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $9.4M |
| Income Before Tax | -$98M |
| Income Tax Expense | -$167K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$98M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$98M |
| Ebitda | -$89M |
| Net Income | -$98M |
SGMO News
SGMO Profile
Sangamo Therapeutics Inc Profile
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic drugs that transform the lives of patients using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company is headquartered in Brisbane, California.
PSTV 75.94%
$0.329
ICU 18.49%
$0.4261
GNLN -19.10%
$0.0072
HCTI -7.88%
$0.0304
NVDA 4.27%
$154.215
QS 32.47%
$5.7358
DNN -3.33%
$1.74
LCID -1.38%
$2.14
VOR 51.52%
$0.482
TSLA -4.56%
$324.9486
SRFM -25.14%
$2.695
SONM 7.14%
$1.2
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
SMCI 8.13%
$46.3217
F -2.24%
$10.49
SAFX
36.89%
$2.3409
BP 1.54%
$30.29
AMD 3.23%
$142.9007
ABEV -2.92%
$2.33
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 13.39%
$4.91
HIMS -1.79%
$42.18
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
INTC -1.22%
$22.275
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
CRCL
-9.57%
$201.3488
WULF 0.39%
$3.855
BTE 0.83%
$1.825
PLUG -4.32%
$1.1099
ONDS 0.94%
$1.605
QXO -6.36%
$22.015
WBD -0.28%
$10.8698
HOOD 0.68%
$82.565
RIG -2.22%
$2.64
MARA 0.50%
$14.955
DFS -0.21%
$200.05
VALE -1.24%
$9.0954
RIOT -0.75%
$9.945
NCNA -5.19%
$0.0858
CUTR -10.19%
$0.0969
NVTS -1.77%
$7.2199
AAL -3.39%
$10.985
APLD -4.88%
$9.8162
ACHR -5.73%
$10.115
AAPL 0.51%
$201.3188
ITUB -2.82%
$6.5982
BTG 0.70%
$3.585
CLSK 5.60%
$10.6019
GRAB -2.53%
$4.62
SOUN -1.75%
$9.6478
CAN -5.45%
$0.6141
GOOGL 2.07%
$170.22
COIN 1.49%
$349.9712
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 13.97%
$0.8753
AG 0.66%
$8.1128
GCTK 33.66%
$8.3
QBTS -2.64%
$14.575
LDTC -19.74%
$0.1525
RZLV 3.96%
$2.8901
ULY 78.18%
$8.0019
SHEL -1.05%
$69.4
RGTI -0.46%
$11.4471
IREN 3.86%
$11.985
QSI 7.71%
$2.025
CIFR 0.13%
$3.855
BBD -1.16%
$2.995
AMZN -0.55%
$211.59
GNS 7.10%
$0.7465
BAC 0.61%
$46.945
MU -1.39%
$126.1345
IQ -3.37%
$1.72
ADIL 8.24%
$0.2482
MLGO 5.48%
$0.6119
ASTS -5.35%
$50.3729
CCL -1.14%
$25.4072
NIO -1.09%
$3.4619
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
EQX 0.60%
$5.865
GOOG 2.09%
$171.24
PBR -0.71%
$12.322
RXRX -1.92%
$5.12
HL -0.03%
$5.798
MULN -12.87%
$0.88
SBET 6.38%
$10.2762
PFE -0.19%
$24.265
PCG -1.85%
$13.8987
NGD 0.21%
$4.86
IBO 15.48%
$0.97
QUBT -5.51%
$16.56
RUN -0.56%
$7.16
PSTV 75.94%
$0.329
ICU 18.49%
$0.4261
GNLN -19.10%
$0.0072
HCTI -7.88%
$0.0304
NVDA 4.27%
$154.215
QS 32.47%
$5.7358
DNN -3.33%
$1.74
LCID -1.38%
$2.14
VOR 51.52%
$0.482
TSLA -4.56%
$324.9486
SRFM -25.14%
$2.695
SONM 7.14%
$1.2
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
SMCI 8.13%
$46.3217
F -2.24%
$10.49
SAFX
36.89%
$2.3409
BP 1.54%
$30.29
AMD 3.23%
$142.9007
ABEV -2.92%
$2.33
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 13.39%
$4.91
HIMS -1.79%
$42.18
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
INTC -1.22%
$22.275
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
CRCL
-9.57%
$201.3488
WULF 0.39%
$3.855
BTE 0.83%
$1.825
PLUG -4.32%
$1.1099
ONDS 0.94%
$1.605
QXO -6.36%
$22.015
WBD -0.28%
$10.8698
HOOD 0.68%
$82.565
RIG -2.22%
$2.64
MARA 0.50%
$14.955
DFS -0.21%
$200.05
VALE -1.24%
$9.0954
RIOT -0.75%
$9.945
NCNA -5.19%
$0.0858
CUTR -10.19%
$0.0969
NVTS -1.77%
$7.2199
AAL -3.39%
$10.985
APLD -4.88%
$9.8162
ACHR -5.73%
$10.115
AAPL 0.51%
$201.3188
ITUB -2.82%
$6.5982
BTG 0.70%
$3.585
CLSK 5.60%
$10.6019
GRAB -2.53%
$4.62
SOUN -1.75%
$9.6478
CAN -5.45%
$0.6141
GOOGL 2.07%
$170.22
COIN 1.49%
$349.9712
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 13.97%
$0.8753
AG 0.66%
$8.1128
GCTK 33.66%
$8.3
QBTS -2.64%
$14.575
LDTC -19.74%
$0.1525
RZLV 3.96%
$2.8901
ULY 78.18%
$8.0019
SHEL -1.05%
$69.4
RGTI -0.46%
$11.4471
IREN 3.86%
$11.985
QSI 7.71%
$2.025
CIFR 0.13%
$3.855
BBD -1.16%
$2.995
AMZN -0.55%
$211.59
GNS 7.10%
$0.7465
BAC 0.61%
$46.945
MU -1.39%
$126.1345
IQ -3.37%
$1.72
ADIL 8.24%
$0.2482
MLGO 5.48%
$0.6119
ASTS -5.35%
$50.3729
CCL -1.14%
$25.4072
NIO -1.09%
$3.4619
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
EQX 0.60%
$5.865
GOOG 2.09%
$171.24
PBR -0.71%
$12.322
RXRX -1.92%
$5.12
HL -0.03%
$5.798
MULN -12.87%
$0.88
SBET 6.38%
$10.2762
PFE -0.19%
$24.265
PCG -1.85%
$13.8987
NGD 0.21%
$4.86
IBO 15.48%
$0.97
QUBT -5.51%
$16.56
RUN -0.56%
$7.16
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.